ArticleInternational journal of hematology2023
Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system.
Haruya Okamoto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.